Marcel Ballin News Today

Physical activity remains essential for public health, offering benefits beyond cardiovascular well-being. TheHealthSite.com

There is a well-known relationship between good physical fitness at a young age and a lower risk of cardiovascular disease later in life.

<p><strong>There is a well-known relationship between good physical fitness at a young age and a lower risk of cardiovascular disease later in life. However, when researchers adjusted for familial factors by means of sibling analysis, they found a weaker association, although the link between high body mass index (BMI) and cardiovascular disease remained strong. The study, which was conducted by researchers from Karolinska Institutet and other universities, is published in <em>...

Researchers noted that the protection wanes at different speeds depending on the type of vaccine used

Researchers noted that the protection wanes at different speeds depending on the type of vaccine used.

Researchers noted that the protection wanes at different speeds depending on the type of vaccine used

LONDON, Feb 8: The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. Researchers noted that the protection wanes at different speeds depending on the type of vaccine used. “The bad news is that the protection against infection seems to be diminished by seven months after the second dose of vaccine,” said Peter Nordstrom, a prof...

The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe Covid-19 appears to be better maintained, according to a study published in The Lancet journal. Researchers noted that the protection wanes at different speeds depending on the type of vaccine used. "The bad news is that the protection against infection seems to

Findings from a recent study suggest that mixing one dose of an mRNA COVID-19 vaccine with a vector-based vaccine could provide more protection.

People who had received a first dose of the Oxford-AstraZeneca COVID-19 vaccine and received an mRNA vaccine for their second dose had a lower risk of infection compared to people who had received both doses of the Oxford-AstraZeneca vaccine.